En Bloc TURBT With Collins Loop vs Conventional TURBT
Launched by HOSPITAL UNIVERSITARIO DE FUENLABRADA · Aug 24, 2021
Trial Information
Current as of July 22, 2025
Unknown status
Keywords
ClinConnect Summary
The main objective of the study is to assess the quality of the resection, defined as the presence of detrusor muscle in the resected tissue.
The secondary objetives are:
* Compare the surgical time, hospital stay, urinary catheterization time and incidence of complications.
* Compare tumor recurrence after one year of follow up.
* Determine the number of re-TURB as a consequence of the absence of muscle layer in the sample or artifacts (Tx)
* Establish the incidence of conversions as a consequence of difficulties in the technique or intraoperative bleeding.
* Compare the degree of satisf...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \>18 years old.
- • Polypoid / sessile primary tumor.
- • \< 3 tumors
- • Tumor size 10 - 30 mm.
- Exclusion Criteria:
- • \> 4 tumors
- • Size of the largest tumor \<1 cm and\> 4 cm.
- • Tumor located in the bladder dome.
- • No visualization of the ureteral meatus.
- • Flat or in situ tumor.
- • Non-urothelial tumors.
- • Clotting disorder or treatment with oral anticoagulants.
About Hospital Universitario De Fuenlabrada
Hospital Universitario de Fuenlabrada is a leading healthcare institution in Spain, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent academic hospital, it combines clinical excellence with cutting-edge research, fostering collaborations among healthcare professionals, researchers, and academic institutions. The hospital is committed to enhancing therapeutic options and contributing to the scientific community by conducting rigorous and ethically sound clinical studies across various medical specialties. Its state-of-the-art facilities and multidisciplinary approach ensure a comprehensive environment for the development of new treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fuenlabrada, Madrid, Spain
Patients applied
Trial Officials
emilio f ripalda, MD
Principal Investigator
Hospital Universitario de Fuenlabrada
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials